Drawing for BIODYNAMIC REPRESENTATIONS

USPTO serial 97372083

BIODYNAMIC REPRESENTATIONS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SCHUTZ, MARISA C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIODYNAMIC REPRESENTATIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software using artificial intelligence, computational methods, and machine learning models for data analysis in the fields of healthcare, wellness, nervous system dysregulation, disease, biomedical, and genomic research; Downloadable computer software using artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in the field of drug discovery and development; Downloadable computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information, and artificial intelligence in the fields of healthcare, biomedical, and genomic research; Downloadable computer software using artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risksACTIVE—
042Providing on-line non-downloadable software using artificial intelligence, computational methods, and machine learning models for data analysis in the fields of healthcare, wellness, nervous system dysregulation, disease, biomedical, and genomic research; Providing on-line non-downloadable software using artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in the field of drug discovery and development; Providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information, and artificial intelligence in the fields of healthcare, biomedical, and genomic research; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to healthcare, wellness, system dysregulation, disease, and genomics; Providing on-line non-downloadable software using artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 3, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 3, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 20, 2026EX5GSOU EXTENSION 5 GRANTED—
May 20, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 22, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 21, 2025EXT5SOU EXTENSION 5 FILED—
Jun 27, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 26, 2025EX4GSOU EXTENSION 4 GRANTED—
Jun 26, 2025EXT4SOU EXTENSION 4 FILED—
Jun 26, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 23, 2024EX3GSOU EXTENSION 3 GRANTED—
Dec 23, 2024EXT3SOU EXTENSION 3 FILED—
Dec 23, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 26, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2024EX2GSOU EXTENSION 2 GRANTED—
Jun 24, 2024EXT2SOU EXTENSION 2 FILED—
Jun 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 20, 2023EX1GSOU EXTENSION 1 GRANTED—
Dec 20, 2023EXT1SOU EXTENSION 1 FILED—
Dec 20, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 2, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 2, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 12, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 30, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2023DOCKASSIGNED TO EXAMINER—
Apr 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance